111 related articles for article (PubMed ID: 22435555)
41. Epigenetic Regulation of Inflammatory Signaling and Inflammation-Induced Cancer.
Tan SYX; Zhang J; Tee WW
Front Cell Dev Biol; 2022; 10():931493. PubMed ID: 35757000
[TBL] [Abstract][Full Text] [Related]
42. Conserved regulatory logic at accessible and inaccessible chromatin during the acute inflammatory response in mammals.
Alizada A; Khyzha N; Wang L; Antounians L; Chen X; Khor M; Liang M; Rathnakumar K; Weirauch MT; Medina-Rivera A; Fish JE; Wilson MD
Nat Commun; 2021 Jan; 12(1):567. PubMed ID: 33495464
[TBL] [Abstract][Full Text] [Related]
43. Transcriptome Profiling of Bovine Macrophages Infected by
Ariel O; Gendron D; Dudemaine PL; Gévry N; Ibeagha-Awemu EM; Bissonnette N
Front Immunol; 2019; 10():2874. PubMed ID: 31969876
[No Abstract] [Full Text] [Related]
44. Distinct mechanisms regulate IL1B gene transcription in lymphoid CD4 T cells and monocytes.
Pulugulla SH; Packard TA; Galloway NLK; Grimmett ZW; Doitsh G; Adamik J; Galson DL; Greene WC; Auron PE
Cytokine; 2018 Nov; 111():373-381. PubMed ID: 30300855
[TBL] [Abstract][Full Text] [Related]
45. Proteasome inhibition induces IKK-dependent interleukin-8 expression in triple negative breast cancer cells: Opportunity for combination therapy.
Uddin MM; Zou Y; Sharma T; Gatla HR; Vancurova I
PLoS One; 2018; 13(8):e0201858. PubMed ID: 30089134
[TBL] [Abstract][Full Text] [Related]
46. Catalpol protects mice against Lipopolysaccharide/D-galactosamine-induced acute liver injury through inhibiting inflammatory and oxidative response.
Zhang H; Jia R; Wang F; Qiu G; Qiao P; Xu X; Wu D
Oncotarget; 2018 Jan; 9(3):3887-3894. PubMed ID: 29423091
[TBL] [Abstract][Full Text] [Related]
47. Combination Therapies Targeting HDAC and IKK in Solid Tumors.
Vancurova I; Uddin MM; Zou Y; Vancura A
Trends Pharmacol Sci; 2018 Mar; 39(3):295-306. PubMed ID: 29233541
[TBL] [Abstract][Full Text] [Related]
48. Mutant p53 shapes the enhancer landscape of cancer cells in response to chronic immune signaling.
Rahnamoun H; Lu H; Duttke SH; Benner C; Glass CK; Lauberth SM
Nat Commun; 2017 Sep; 8(1):754. PubMed ID: 28963538
[TBL] [Abstract][Full Text] [Related]
49. Dehydrocostus lactone, a natural sesquiterpene lactone, suppresses the biological characteristics of glioma, through inhibition of the NF-κB/COX-2 signaling pathway by targeting IKKβ.
Wang J; Yu Z; Wang C; Tian X; Huo X; Wang Y; Sun C; Feng L; Ma J; Zhang B; Yang Q; Ma X; Xu Y
Am J Cancer Res; 2017; 7(6):1270-1284. PubMed ID: 28670490
[TBL] [Abstract][Full Text] [Related]
50. The Unique Molecular and Cellular Microenvironment of Ovarian Cancer.
Worzfeld T; Pogge von Strandmann E; Huber M; Adhikary T; Wagner U; Reinartz S; Müller R
Front Oncol; 2017; 7():24. PubMed ID: 28275576
[TBL] [Abstract][Full Text] [Related]
51. Histone Deacetylase (HDAC) Inhibition Induces IκB Kinase (IKK)-dependent Interleukin-8/CXCL8 Expression in Ovarian Cancer Cells.
Gatla HR; Zou Y; Uddin MM; Singha B; Bu P; Vancura A; Vancurova I
J Biol Chem; 2017 Mar; 292(12):5043-5054. PubMed ID: 28167529
[TBL] [Abstract][Full Text] [Related]
52. TLR ligands, but not modulators of histone modifiers, can induce the complex immune response pattern of endotoxin tolerance in mammary epithelial cells.
Günther J; Petzl W; Zerbe H; Schuberth HJ; Seyfert HM
Innate Immun; 2017 Feb; 23(2):155-164. PubMed ID: 27913794
[TBL] [Abstract][Full Text] [Related]
53. Evidence for a quadruplex structure in the polymorphic hs1.2 enhancer of the immunoglobulin heavy chain 3' regulatory regions and its conservation in mammals.
Sette M; D'Addabbo P; Kelly G; Cicconi A; Micheli E; Cacchione S; Poma A; Gargioli C; Giambra V; Frezza D
Biopolymers; 2016 Nov; 105(11):768-78. PubMed ID: 27287611
[TBL] [Abstract][Full Text] [Related]
54. Hsp90 inhibition suppresses NF-κB transcriptional activation via Sirt-2 in human lung microvascular endothelial cells.
Thangjam GS; Birmpas C; Barabutis N; Gregory BW; Clemens MA; Newton JR; Fulton D; Catravas JD
Am J Physiol Lung Cell Mol Physiol; 2016 May; 310(10):L964-74. PubMed ID: 27036868
[TBL] [Abstract][Full Text] [Related]
55. Tubular Epithelial NF-κB Activity Regulates Ischemic AKI.
Markó L; Vigolo E; Hinze C; Park JK; Roël G; Balogh A; Choi M; Wübken A; Cording J; Blasig IE; Luft FC; Scheidereit C; Schmidt-Ott KM; Schmidt-Ullrich R; Müller DN
J Am Soc Nephrol; 2016 Sep; 27(9):2658-69. PubMed ID: 26823548
[TBL] [Abstract][Full Text] [Related]
56. Genome-wide predictors of NF-κB recruitment and transcriptional activity.
Cieślik M; Bekiranov S
BioData Min; 2015; 8():37. PubMed ID: 26617673
[TBL] [Abstract][Full Text] [Related]
57. Transcriptional repression by the HDAC4-RelB-p52 complex regulates multiple myeloma survival and growth.
Vallabhapurapu SD; Noothi SK; Pullum DA; Lawrie CH; Pallapati R; Potluri V; Kuntzen C; Khan S; Plas DR; Orlowski RZ; Chesi M; Kuehl WM; Bergsagel PL; Karin M; Vallabhapurapu S
Nat Commun; 2015 Oct; 6():8428. PubMed ID: 26455434
[TBL] [Abstract][Full Text] [Related]
58. Down-regulation of IKKβ expression in glioma-infiltrating microglia/macrophages is associated with defective inflammatory/immune gene responses in glioblastoma.
Mieczkowski J; Kocyk M; Nauman P; Gabrusiewicz K; Sielska M; Przanowski P; Maleszewska M; Rajan WD; Pszczolkowska D; Tykocki T; Grajkowska W; Kotulska K; Roszkowski M; Kostkiewicz B; Kaminska B
Oncotarget; 2015 Oct; 6(32):33077-90. PubMed ID: 26427514
[TBL] [Abstract][Full Text] [Related]
59. Dynamic aberrant NF-κB spurs tumorigenesis: a new model encompassing the microenvironment.
Vlahopoulos SA; Cen O; Hengen N; Agan J; Moschovi M; Critselis E; Adamaki M; Bacopoulou F; Copland JA; Boldogh I; Karin M; Chrousos GP
Cytokine Growth Factor Rev; 2015 Aug; 26(4):389-403. PubMed ID: 26119834
[TBL] [Abstract][Full Text] [Related]
60. The Werner Protein Acts as a Coactivator of Nuclear Factor κB (NF-κB) on HIV-1 and Interleukin-8 (IL-8) Promoters.
Mizutani T; Ishizaka A; Furuichi Y
J Biol Chem; 2015 Jul; 290(30):18391-9. PubMed ID: 26037922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
